Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Intervalo de año de publicación
1.
BMC Anesthesiol ; 24(1): 164, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38693477

RESUMEN

BACKGROUND: Post-operative sore throat (POST) has an incidence ranging from 21 to 80%. To prevent the development of POST, several pharmacological measures have been tried. Aim of this study was to compare the efficacy of preoperative zinc, magnesium and budesonide gargles in reducing the incidence and severity of POST in patients who underwent endotracheal intubation for elective surgeries. METHODS: We conducted a prospective, randomized, double-blind, controlled equivalence trial in 180 patients admitted for elective surgical procedures under general anaesthesia. Patients were randomised into three groups; group Z received 40 mg Zinc, group M received 250 mg Magnesium Sulphate and group B received 200 µg Budesonide in the form of 30 ml tasteless and colourless gargle solutions. Sore throat assessment and haemodynamic recording was done postoperatively at immediate recovery (0 h) and 2, 4, 6, 8, 12 and 24 h post-operatively. POST was graded on a four-point scale (0-3). RESULTS: POST score was comparable at all recorded time points i.e. 0,2,4,6,8,12 and 24 h. Maximum incidence was seen at 8 h in group B (33.3%) and the minimum incidence was at 24 h in group Z (10%) (p > 0.05). It was found that the incidence of POST was more in the surgeries lasting longer than 2 h in all groups. This difference was found to be statistically significant in Groups M and B. The incidence of POST was found to be comparable between laparoscopic and open procedures. CONCLUSION: Magnesium, zinc and budesonide have an equivocal effect in the prevention of POST at different time points. The incidence of sore throat increases significantly in surgeries lasting more than two hours if magnesium or budesonide have been used as premedicant. Duration of surgery is an independent predictor for POST. TRIAL REGISTRATION: CTRI/2021/05/033741 Date-24/05/2021(Clinical Trial Registry of India).


Asunto(s)
Budesonida , Sulfato de Magnesio , Faringitis , Complicaciones Posoperatorias , Cuidados Preoperatorios , Zinc , Humanos , Faringitis/prevención & control , Faringitis/etiología , Budesonida/administración & dosificación , Budesonida/uso terapéutico , Método Doble Ciego , Femenino , Masculino , Estudios Prospectivos , Adulto , Complicaciones Posoperatorias/prevención & control , Complicaciones Posoperatorias/epidemiología , Cuidados Preoperatorios/métodos , Zinc/administración & dosificación , Persona de Mediana Edad , Sulfato de Magnesio/administración & dosificación , Intubación Intratraqueal , Magnesio/administración & dosificación , Incidencia , Procedimientos Quirúrgicos Electivos , Adulto Joven , Anestesia General/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA